Franklin Resources’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,594
Closed -$8.98K 3237
2025
Q2
$8.98K Hold
16,594
﹤0.01% 2989
2025
Q1
$10.9K Buy
+16,594
New +$17.6K ﹤0.01% 2927
2024
Q1
Sell
-32,786
Closed -$17.8K 2951
2023
Q4
$17.8K Buy
32,786
+436
+1% +$201 ﹤0.01% 2578
2023
Q3
$19.4K Buy
32,350
+5,350
+20% +$5.73K ﹤0.01% 2600
2023
Q2
$35.1K Sell
27,000
-7,200
-21% -$9.84K ﹤0.01% 2637
2023
Q1
$60.2K Buy
34,200
+7,119
+26% +$20.3K ﹤0.01% 2171
2022
Q4
$85K Buy
27,081
+81
+0.3% +$314 ﹤0.01% 2153
2022
Q3
$132K Buy
+27,000
New +$139K ﹤0.01% 2062
2015
Q3
Sell
-716,300
Closed -$7.94M 1623
2015
Q2
$7.94M Hold
716,300
﹤0.01% 1086
2015
Q1
$11.2M Hold
716,300
0.01% 1026
2014
Q4
$10.9M Sell
716,300
-53,500
-7% -$650K ﹤0.01% 1034
2014
Q3
$8.3M Sell
769,800
-185,600
-19% -$2.42M ﹤0.01% 1078
2014
Q2
$14.6M Sell
955,400
-140,700
-13% -$2.02M 0.01% 962
2014
Q1
$19.8M Buy
+1,096,100
New +$21.1M 0.01% 862

Other funds holding SGMO

Franklin Resources's SGMO Position: Q3 2025 in Review

Franklin Resources sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2025, closing a stake of 16,594 shares — an estimated $8.98K sold.

Franklin Resources first reported a position in SGMO in Q1 2014 and held it in 14 quarters. The position peaked at $19.8M in Q1 2014. 112 funds tracked by Wall St. Rank hold SGMO as of Q3 2025.

  • Franklin Resources reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2025 after selling out during the quarter.
  • Franklin Resources sold 16,594 SANGAMO THERAPEUTICS INC shares in Q3 2025, an estimated $8.98K.
  • Franklin Resources first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 14 quarters.
  • Franklin Resources's SANGAMO THERAPEUTICS INC position peaked at $19.8M in Q1 2014.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2025.

Based on Franklin Resources's 13F filing for Q3 2025, filed 13 Nov 2025.